Oxyntic atrophy, metaplasia, and gastric cancer

James R. Goldenring, Ki Taek Nam

Research output: Chapter in Book/Report/Conference proceedingChapter

29 Citations (Scopus)

Abstract

Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacement of the normal gastric lineages with metaplastic cells. In humans, two metaplastic lineages develop as sequelae of chronic Helicobacter pylori infection: intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM). Mouse models of both chronic Helicobacter infection and acute pharmacological oxyntic atrophy have led to the discovery that SPEM arises from transdifferentiation of mature chief cells. The presence of inflammation promotes the expansion of SPEM in mice. Furthermore, studies in Mongolian gerbils as well as increasing evidence from human studies indicate that SPEM likely represents a precursor for the development of intestinal metaplasia. These findings suggest that loss of parietal cells, augmented by chronic inflammation, leads to a cascade of metaplastic events. Identification of specific biomarkers for SPEM and intestinal metaplasia hold promise for providing both early detection of preneoplasia and information on prognostic outcome following curative resection.

Original languageEnglish
Title of host publicationProgress in Molecular Biology and Translational Science
PublisherElsevier B.V.
Pages117-131
Number of pages15
EditionC
DOIs
Publication statusPublished - 2010 Jan 1

Publication series

NameProgress in Molecular Biology and Translational Science
NumberC
Volume96
ISSN (Print)1877-1173

Fingerprint

Metaplasia
Stomach Neoplasms
Atrophy
Helicobacter Infections
Stomach
Gastric Parietal Cells
Inflammation
Gerbillinae
Helicobacter pylori
Carcinogenesis
Biomarkers
spasmolytic polypeptide
Pharmacology

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology

Cite this

Goldenring, J. R., & Nam, K. T. (2010). Oxyntic atrophy, metaplasia, and gastric cancer. In Progress in Molecular Biology and Translational Science (C ed., pp. 117-131). (Progress in Molecular Biology and Translational Science; Vol. 96, No. C). Elsevier B.V.. https://doi.org/10.1016/B978-0-12-381280-3.00005-1
Goldenring, James R. ; Nam, Ki Taek. / Oxyntic atrophy, metaplasia, and gastric cancer. Progress in Molecular Biology and Translational Science. C. ed. Elsevier B.V., 2010. pp. 117-131 (Progress in Molecular Biology and Translational Science; C).
@inbook{b95e8e8116d44714b99e58cd24e1d314,
title = "Oxyntic atrophy, metaplasia, and gastric cancer",
abstract = "Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacement of the normal gastric lineages with metaplastic cells. In humans, two metaplastic lineages develop as sequelae of chronic Helicobacter pylori infection: intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM). Mouse models of both chronic Helicobacter infection and acute pharmacological oxyntic atrophy have led to the discovery that SPEM arises from transdifferentiation of mature chief cells. The presence of inflammation promotes the expansion of SPEM in mice. Furthermore, studies in Mongolian gerbils as well as increasing evidence from human studies indicate that SPEM likely represents a precursor for the development of intestinal metaplasia. These findings suggest that loss of parietal cells, augmented by chronic inflammation, leads to a cascade of metaplastic events. Identification of specific biomarkers for SPEM and intestinal metaplasia hold promise for providing both early detection of preneoplasia and information on prognostic outcome following curative resection.",
author = "Goldenring, {James R.} and Nam, {Ki Taek}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-381280-3.00005-1",
language = "English",
series = "Progress in Molecular Biology and Translational Science",
publisher = "Elsevier B.V.",
number = "C",
pages = "117--131",
booktitle = "Progress in Molecular Biology and Translational Science",
edition = "C",

}

Goldenring, JR & Nam, KT 2010, Oxyntic atrophy, metaplasia, and gastric cancer. in Progress in Molecular Biology and Translational Science. C edn, Progress in Molecular Biology and Translational Science, no. C, vol. 96, Elsevier B.V., pp. 117-131. https://doi.org/10.1016/B978-0-12-381280-3.00005-1

Oxyntic atrophy, metaplasia, and gastric cancer. / Goldenring, James R.; Nam, Ki Taek.

Progress in Molecular Biology and Translational Science. C. ed. Elsevier B.V., 2010. p. 117-131 (Progress in Molecular Biology and Translational Science; Vol. 96, No. C).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Oxyntic atrophy, metaplasia, and gastric cancer

AU - Goldenring, James R.

AU - Nam, Ki Taek

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacement of the normal gastric lineages with metaplastic cells. In humans, two metaplastic lineages develop as sequelae of chronic Helicobacter pylori infection: intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM). Mouse models of both chronic Helicobacter infection and acute pharmacological oxyntic atrophy have led to the discovery that SPEM arises from transdifferentiation of mature chief cells. The presence of inflammation promotes the expansion of SPEM in mice. Furthermore, studies in Mongolian gerbils as well as increasing evidence from human studies indicate that SPEM likely represents a precursor for the development of intestinal metaplasia. These findings suggest that loss of parietal cells, augmented by chronic inflammation, leads to a cascade of metaplastic events. Identification of specific biomarkers for SPEM and intestinal metaplasia hold promise for providing both early detection of preneoplasia and information on prognostic outcome following curative resection.

AB - Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacement of the normal gastric lineages with metaplastic cells. In humans, two metaplastic lineages develop as sequelae of chronic Helicobacter pylori infection: intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM). Mouse models of both chronic Helicobacter infection and acute pharmacological oxyntic atrophy have led to the discovery that SPEM arises from transdifferentiation of mature chief cells. The presence of inflammation promotes the expansion of SPEM in mice. Furthermore, studies in Mongolian gerbils as well as increasing evidence from human studies indicate that SPEM likely represents a precursor for the development of intestinal metaplasia. These findings suggest that loss of parietal cells, augmented by chronic inflammation, leads to a cascade of metaplastic events. Identification of specific biomarkers for SPEM and intestinal metaplasia hold promise for providing both early detection of preneoplasia and information on prognostic outcome following curative resection.

UR - http://www.scopus.com/inward/record.url?scp=78649262354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649262354&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-381280-3.00005-1

DO - 10.1016/B978-0-12-381280-3.00005-1

M3 - Chapter

C2 - 21075342

AN - SCOPUS:78649262354

T3 - Progress in Molecular Biology and Translational Science

SP - 117

EP - 131

BT - Progress in Molecular Biology and Translational Science

PB - Elsevier B.V.

ER -

Goldenring JR, Nam KT. Oxyntic atrophy, metaplasia, and gastric cancer. In Progress in Molecular Biology and Translational Science. C ed. Elsevier B.V. 2010. p. 117-131. (Progress in Molecular Biology and Translational Science; C). https://doi.org/10.1016/B978-0-12-381280-3.00005-1